Search Within

Jacqueline Michelle Gallagher

Formats
  1. Journal Article (3)
  2. Meeting Abstract (2)
Groups
  1. Department of Medicine (5)
  2. GDMT, Medicine (5)
  3. Gynecologic Medicine Service (5)
  4. Gynecology Disease Management Team (5)
  5. Solid Tumor Oncology Division (5)
  6. Biostatistics Service (4)

More Groups

People
  1. Carol Aghajanian (5)
  2. Alexia Iasonos (4)
  3. Qin Zhou (4)
  4. Sara Kravetz (4)
  5. Vicky Makker (4)
  6. Dmitriy Zamarin (3)

More People

Years
  1. 2020 (2)
  2. 2019 (1)
  3. 2013 (2)
Publications
  1. Clinical Cancer Research (1)
  2. Gynecologic Oncology (1)
  3. International Journal of Gynecological Cancer (1)
  4. Journal for ImmunoTherapy of Cancer (1)
  5. Journal of Clinical Oncology (1)
Publishers
  1. American Association for Cancer Research (1)
  2. American Society of Clinical Oncology (1)
  3. Biomed Central Ltd (1)
  4. Elsevier Inc. (1)
  5. Lippincott Williams & Wilkins (1)

Results (5)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Safety, immunogenicity, and clinical efficacy of durvalumab in combination with folate receptor alpha vaccine TPIV200 in patients with advanced ovarian cancer: A phase II trial
    Journal Article

    Zamarin, D.; Walderich, S.; Holland, A.; Zhou, Q.; Iasonos, A. E.; Torrisi, J. M.; Merghoub, T.; Chesebrough, L. F.; Mcdonnell, A. S.; Gallagher, J. M.; more...
    Journal for ImmunoTherapy of Cancer (2020)

    Fulltext@MSK | Save
  • A phase 1 dose-escalation study of intraperitoneal cisplatin, intravenous/intraperitoneal paclitaxel, bevacizumab, and olaparib for newly diagnosed ovarian cancer
    Journal Article

    Cadoo, K. A.; Grisham, R. N.; O'Cearbhaill, R. E.; Boucicaut, N. N.; Henson, M.; Iasonos, A.; Zhou, Q.; Sarasohn, D. M.; Gallagher, J.; Kravetz, S.; more...
    Gynecologic Oncology (2020)

    Fulltext@MSK | Save
  • A phase 2 study of TPIV200/ huFR-1 (a multi-epitope folate receptor alpha vaccine) in combination with durvalumab in patients with platinum resistant ovarian cancer
    Meeting Abstract

    Zamarin, D.; Yeku, O.; O'Cearbhaill, R. E.; Cadoo, K. A.; Gallagher, J.; Kravetz, S.; McDonnell, A.; Troso-Sandoval, T.; Sabbatini, P.; Lichtman, S.; more...
    Clinical Cancer Research (2019)

    Fulltext@MSK | Save
  • A retrospective assessment of outcomes of chemotherapy-based versus radiation-only adjuvant treatment for completely resected stage I-IV uterine carcinosarcoma (UCS) with rhabdomyosarcoma (RMS) differentiation
    Meeting Abstract

    Makker, V.; Kravetz, S. J.; Gallagher, J.; Orodel, O.; Iasonos, A.; DeLair, D.; Zhou, Q.; Aghajanian, C.; Hensley, M. L.
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Treatment outcomes in completely resected stage i to stage iv uterine carcinosarcoma with rhabdomyosarcoma differentiation
    Journal Article

    Makker, V.; Kravetz, S. J.; Gallagher, J.; Orodel, O. P.; Zhou, Q.; Iasonos, A.; DeLair, D.; Aghajanian, C.; Hensley, M. L.
    International Journal of Gynecological Cancer (2013)

    Fulltext@MSK | Save